Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades Elanco Animal Health to Neutral

JP Morgan Downgrades Elanco Animal Health to Neutral

JP Morgan analyst Chris Schott downgrades Elanco Animal Health (NYSE:ELAN) from Overweight to Neutral.

byBenzinga Newsdesk

August 16, 2022

1 minute read

JP Morgan analyst Chris Schott downgrades Elanco Animal Health (NYSE:ELAN) from Overweight to Neutral.

Recap: WNS (Holdings) Q1 Earnings

By Benzinga Insights

Yesterday, 7:16 AM

WNS (Hldgs) (NYSE:WNS) reported its Q1 earnings results on Thursday, July 21, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

WNS

Needham Maintains Buy on NextCure, Lowers Price Target to $6

By Benzinga Newsdesk

November 4, 10:43 AM

Needham analyst Gil Blum maintains NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $12 to $6.

NXTC

P/E Ratio Insights for Textron

By Benzinga Insights

April 10, 10:30 AM

In the current market session, Textron Inc. (NYSE:TXT) share price is at $68.31, after a 0.89% increase. Moreover,…

TXT

Nord Stream Said Damage to Gas Pipeline to Germany is Unprecedented

By Charles Gross

September 27, 5:34 AM

-Bloomberg https://www.bloomberg.com/news/articles/2022-09-27/nord-stream-probing-pressure-drop-at-second-russian-gas-link

UNG

JP Morgan Downgrades Elanco Animal Health to Neutral

Related Posts

Recap: WNS (Holdings) Q1 Earnings

Needham Maintains Buy on NextCure, Lowers Price Target to $6

P/E Ratio Insights for Textron

Nord Stream Said Damage to Gas Pipeline to Germany is Unprecedented